Activists gathered with signs outside Merck’s East London offices last week, protesting the drugmaker’s involvement in a campaign to delay South Africa’s proposal to allow low-cost copies of patented drugs.
Merck & Co. agreed to pay $100 million to settle several thousand lawsuits alleging the drugmaker’s NuvaRing contraceptive device causes potentially fatal blood clots, two people familiar with the accord said.
Pfizer Inc., Eli Lilly & Co. and eight other large drugmakers will partner with the U.S. government in a $230 million effort to identify new approaches to treat Alzheimer’s, diabetes, lupus and arthritis.
A dispute has erupted within the pharmaceutical industry over how to respond to a government proposal in South Africa to allow local manufacturers to copy brand-name drugs and sell them in the country at a lower cost.
Pharmaceutical companies from Merck & Co. to Bristol-Myers Squibb Co. face fresh threats to protecting their patents in India as a government-appointed panel prepares to evaluate more drugs for local makers to copy.
Merck & Co. rose the most in almost five years after saying it will seek early approval of a new cancer treatment and decide the future of the company’s animal health and consumer businesses this year.
Vaccines by Merck & Co. and GlaxoSmithKline Plc used to prevent severe diarrhea in infants may carry a slight risk of bowel blockage, two U.S. studies found. The findings weren’t serious enough to change recommendations for the vaccines’ use, researchers said.